Visual outcomes of vitrectomy for polypoidal choroidal vasculopathy-related breakthrough vitreous haemorrhage

Hc, Lin; Yang, Chia‐Hung; Cm, Yang

doi:10.1038/eye.2014.124

Cited by 16 publications

(21 citation statements)

References 36 publications

(65 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Jung et al, showed that the mean logMAR BCVA significantly improved from 2.79 before the surgery to 1.61 at 2 months after the surgery 12 . The studies by Lin et al (the mean BCVA improved from 2.63 to 1.62 at 3 months after the surgery) 13 and by Narayanan et al, (the mean BCVA improved from 2.69 to 1.65 at 1 month after the surgery) 14 also showed similar outcomes. However, considering the degree of postoperative visual acuity itself, the results were somewhat disappointing with better than 20/200 BCVA achieved in only 2 of the 5 eyes (40.0%) 10 , 6 of 24 eyes (25.0%) 12 , and 5 of 17 eyes (29.4%) 13 .…”

Section: Discussionmentioning

confidence: 74%

See 1 more Smart Citation

Long-term Clinical Course after Vitrectomy for Breakthrough Vitreous Hemorrhage Secondary to Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy

Kim

et al. 2020

Sci Rep

View full text Add to dashboard Cite

Won Lee to investigate the long-term clinical course after vitrectomy for breakthrough vitreous hemorrhage secondary to neovascular age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV). This retrospective study included 45 eyes that underwent vitrectomy due to breakthrough vitreous hemorrhage secondary to neovascular AMD. The patients were divided into 2 groups: neovascular AMD group and PCV group. Within each group, the status of the eye within 6 months after the surgery and that at the final follow-up was identified. The visual acuity at the final visit was additionally compared between the 2 groups. The patients were followed up for a mean period of 39.9 ± 19.4 months after the surgery. In the neovascular AMD group (n = 17), re-bleeding requiring vitrectomy was noted in 4 eyes and extensive scar formation was noted in 6 eyes within 6 months after the surgery. At the final visit, treatment was discontinued due to poor visual outcome in 10 eyes. In the pcV group (n = 28), re-bleeding requiring vitrectomy was noted in 1 eye, and extensive scar formation was noted in 4 eyes within 6 months after the surgery. At the final visit, treatment was discontinued in 8 eyes. The visual acuity at the final visit was significantly better in the PCV group (P = 0.003). The longterm clinical course after vitrectomy for breakthrough vitreous hemorrhage was markedly different between neovascular AMD and PCV, showing significantly better long-term visual outcomes in PCV.

show abstract

Section: Discussionmentioning

confidence: 74%

“…Previous studies have reported the outcomes of vitrectomy in breakthrough vitreous hemorrhage [10][11][12][13][14] . However, these studies were mainly focused on visual outcomes, especially the short-term outcomes after the surgery.…”

mentioning

confidence: 99%

Long-term Clinical Course after Vitrectomy for Breakthrough Vitreous Hemorrhage Secondary to Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy

Kim

et al. 2020

Sci Rep

View full text Add to dashboard Cite

show abstract

“…On HPE, multiple fibrovascular proliferations in the subretinal space within the Bruch membrane may be seen 2. Up to 20% of PCV results in BTB, whereas in AMD it is about 0.6 to 7% 10. Given the prevalence of PCV in our population and the tendency of PCV to cause massive BTB, this was considered as the most likely underlying cause for her haemophthalmus prior to the histopathology result.…”

Section: Discussionmentioning

confidence: 93%

“…In this patient there was evidence of macula involvement. Hence the vision was only finger counting after surgery 10. In a retrospective series of BTB described by Jung et al , vitrectomy was helpful for improving vision.…”

Section: Discussionmentioning

confidence: 99%

Enucleation for haemophthalmus secondary to choroidal neovascularisation in polypoidal choroidal vasculopathy: a therapeutic and diagnostic dilemma

et al. 2016

View full text Add to dashboard Cite

We report a case of enucleation for painful blind eye secondary to recurrent bleeding from choroidal neovascularisation in an eye that was irradiated following presumed metastatic breast carcinoma to the choroid. A 58-year-old woman with a history of treated breast malignancy presented with haemophthalmus and intractable glaucoma in the right eye. One year previously she had presented with right vitreous haemorrhage with subretinal mass that had been irradiated given her history of breast carcinoma. Following irradiation, vitrectomy was performed to clear the blood. Intraoperative and postoperative angiography findings suggested a diagnosis of breakthrough bleeding secondary to polypoidal choroidal vasculopathy. At this presentation, however, the intraocular bleeding was recurrent resulting in elevated intraocular pressure and pain. Despite repeat surgery and medical therapy, the eye had to be enucleated. Histopathology showed choroidal neovascularisation.

show abstract

“…These studies had small series ranging from one to three eyes that underwent vitrectomy. Recent reported outcomes of vitrectomy in PCV did not find a higher incidence of retinal breaks [13, 18]. …”

Section: Discussionmentioning

confidence: 99%

Vitreous haemorrhage in massive hemorrhagic polypoidal choroidal vasculopathy: clinical characteristics and surgical outcomes

et al. 2015

View full text Add to dashboard Cite

BackgroundTo report the outcomes of vitreous hemorrhage (VH) associated with hemorrhagic polypoidal choroidal vasculopathy (PCV).MethodsA retrospective study of 28 eyes of 27 consecutive patients of hemorrhagic PCV with VH, which were managed surgically between January 2003 and December 2011, was performed. All patients underwent pars plana vitrectomy for VH associated with PCV. The main outcome measure was best-corrected visual acuity (BCVA) at baseline, at 1, 3 and 6 months post operatively and at last follow up.ResultsThe visual acuity measured on early treatment diabetic retinopathy study (ETDRS) chart improved in 16 eyes (57.1 %) by two or more lines, remained unchanged in nine eyes (32.1 %) and decreased in three (10.7 %) after surgery when compared to baseline VA. The mean baseline VA was 2.69 ± 0.57 logMAR units (<20/2000) which improved to 1.65 ± 0.93 logMAR units (20/800) at 1 month post operative visit and was sustained at 1.72 ± 1.12 (20/800) with an improvement of 0.96 logMAR units (p < 0.001, 95 % CI 0.54–1.37). The average postoperative follow up was for 14.2 months (range 1–84). The complications noted in postoperative follow up were cataract (n = 10), macular scaring (n = 9), organised dehemoglobinised blood (n = 7), retinal tear or detachment (n = 5), recurrent VH (n = 3) and choroidal detachment (n = 1).ConclusionMajority of patients with loss of vision due to VH secondary to hemorrhagic PCV have sustained improvement in visual acuity following surgery.

show abstract

Visual outcomes of vitrectomy for polypoidal choroidal vasculopathy-related breakthrough vitreous haemorrhage

Cited by 16 publications

References 36 publications

Long-term Clinical Course after Vitrectomy for Breakthrough Vitreous Hemorrhage Secondary to Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy

Long-term Clinical Course after Vitrectomy for Breakthrough Vitreous Hemorrhage Secondary to Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy

Enucleation for haemophthalmus secondary to choroidal neovascularisation in polypoidal choroidal vasculopathy: a therapeutic and diagnostic dilemma

Vitreous haemorrhage in massive hemorrhagic polypoidal choroidal vasculopathy: clinical characteristics and surgical outcomes

Contact Info

Product

Resources

About